Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. (2934)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. (statistical code 2934): exports in August 2026 were JPY 6,668,503,000 (+8.3% year on year), quantity 781,968 KG, unit price JPY 8,515 per KG. Main destinations: United States of America (31.6%), Germany (22.9%), Belgium (9.0%), Italy (7.8%), Republic of Korea (6.1%). Figures for August 2026 are revised.
Imports in the same month were JPY 6,513,953,000, a trade surplus of JPY 154,550,000. (imports: preliminary; exports: revised)
Import statistics for this code
Monthly statistics
| Month | Status | Export value | Quantity | Unit price | Year-on-year |
|---|---|---|---|---|---|
| August 2026 | revised | JPY 6,668,503,000 | 781,968 | JPY 8,515 | +8.3% |
| July 2026 | revised | JPY 12,970,578,000 | 1,257,485 | JPY 10,312 | +6.5% |
| June 2026 | revised | JPY 10,109,903,000 | 975,114 | JPY 10,360 | -20.9% |
| May 2026 | revised | JPY 13,612,295,000 | 1,080,648 | JPY 12,593 | +13.6% |
| April 2026 | revised | JPY 7,436,640,000 | 2,063,237 | JPY 3,604 | -50.2% |
| March 2026 | revised | JPY 14,543,191,000 | 1,302,221 | JPY 11,166 | +4.5% |
| February 2026 | revised | JPY 9,698,274,000 | 1,283,114 | JPY 7,485 | -25.2% |
| January 2026 | revised | JPY 11,110,854,000 | 1,357,618 | JPY 8,184 | -16.2% |
| December 2025 | revised (second) | JPY 6,767,701,000 | 1,082,645 | JPY 6,246 | -43.3% |
| November 2025 | revised (second) | JPY 13,402,924,000 | 1,354,036 | JPY 9,880 | -28.3% |
| October 2025 | revised (second) | JPY 9,686,071,000 | 1,581,823 | JPY 6,054 | -37.6% |
| September 2025 | revised (second) | JPY 10,382,405,000 | 1,297,274 | JPY 8,002 | -41.1% |
| August 2025 | revised (second) | JPY 6,158,305,000 | 1,329,619 | JPY 4,630 | -15.9% |
| July 2025 | revised (second) | JPY 12,179,612,000 | 1,431,336 | JPY 8,509 | +5.9% |
| June 2025 | revised (second) | JPY 12,788,020,000 | 1,070,384 | JPY 11,899 | -25.7% |
| May 2025 | revised (second) | JPY 11,978,239,000 | 1,087,412 | JPY 11,015 | -14.1% |
| April 2025 | revised (second) | JPY 14,939,534,000 | 1,679,829 | JPY 8,893 | +14.6% |
| March 2025 | revised (second) | JPY 13,913,276,000 | 1,340,332 | JPY 10,378 | -5.4% |
| February 2025 | revised (second) | JPY 12,974,186,000 | 1,018,198 | JPY 12,740 | -11.4% |
| January 2025 | revised (second) | JPY 13,262,602,000 | 864,576 | JPY 15,316 | -3.2% |
| December 2024 | final | JPY 11,938,910,000 | 1,167,740 | JPY 10,217 | -21.7% |
| November 2024 | final | JPY 18,691,429,000 | 1,139,798 | JPY 16,397 | +43.9% |
| October 2024 | final | JPY 15,515,218,000 | 1,136,980 | JPY 13,646 | -1.6% |
| September 2024 | final | JPY 17,626,664,000 | 1,171,534 | JPY 15,038 | +20.9% |
Subcategories
- Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure
- Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused
- Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused
- Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof
- Other
API and MCP
No API key required. An optional API key gives you a dedicated quota of 1,000 requests per day that is not affected by congestion (free at https://data.washutrading.com/register/).
Example API request for this item: https://data.washutrading.com/api/v1/series?code=2934&flow=export